We are live on ! Find out more
IVC

Invacare Corporation

Delisted

IVC was delisted on the 31st of January, 2023.

72 hedge funds and large institutions have $14.8M invested in Invacare Corporation in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 30 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 8372 (-11)

44% less capital invested

Capital invested by funds: $26.3M → $14.8M (-$11.6M)

50% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 20

50% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 30

77% less call options, than puts

Call options by funds: $11K | Put options by funds: $48K

Holders
72
Holders Change
-11
Holders Change %
-13.25%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
15
Reduced
30
Closed
20
Calls
$11K
Puts
$48K
Net Calls
-$37K
Net Calls Change
-$9K
Name Holding Trade Value Shares
Change
Change in
Stake
JIC
26
Johnson Investment Counsel
Ohio
$95K +$109 +104 +0.1%
Northern Trust
27
Northern Trust
Illinois
$79K +$2.94K +2,799 +3%
SFI
28
Susquehanna Fundamental Investments
Pennsylvania
$78K +$105K +99,381 New
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$71K +$27.4K +26,000 +40%
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
$66K
SKK
31
Shepherd Kaplan Krochuk
Massachusetts
$56K -$53.1K -50,469 -41%
Cerity Partners
32
Cerity Partners
New York
$54K
RC
33
RBF Capital
California
$43K -$4.1K -3,900 -7%
Barclays
34
Barclays
United Kingdom
$38K -$4.82K -4,584 -9%
IIM
35
Ironwood Investment Management
Massachusetts
$36K
Millennium Management
36
Millennium Management
New York
$33K -$421K -399,604 -90%
BIP
37
Brandes Investment Partners
California
$31K +$5.97K +5,670 +16%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$28K -$310 -295 -0.8%
UBS Group
39
UBS Group
Switzerland
$28K +$4.29K +4,078 +13%
HSBC Holdings
40
HSBC Holdings
United Kingdom
$26K -$4.65K -4,419 -12%
Goldman Sachs
41
Goldman Sachs
New York
$24K -$8.87K -8,424 -21%
EGM
42
Engineers Gate Manager
New York
$22K -$113K -107,523 -79%
Assenagon Asset Management
43
Assenagon Asset Management
Luxembourg
$22K -$42.2K -40,059 -59%
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$21K -$3.85K -3,663 -12%
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$21K +$12K +11,385 +76%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$17K -$79.9K -75,931 -78%
AA
47
Ancora Advisors
Ohio
$17K +$4.21K +4,000 +22%
AQR Capital Management
48
AQR Capital Management
Connecticut
$15K -$583K -554,093 -97%
Simplex Trading
49
Simplex Trading
Illinois
$13K -$1.54K -1,467 -8%
VCAM
50
Van Cleef Asset Management
Ohio
$12K +$16.1K +15,270 New

IVC Hedge Fund Activity: Q3 2022 in Review

72 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Invacare Corporation (IVC) for Q3 2022, worth a combined $14.8M — down 44% from $26.3M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of IVC and 10 opened new positions — a net loss of 10 holders — while 30 trimmed existing stakes and 15 added.

The largest buyer was First Manhattan, adding an estimated $1.48M. The largest seller was Franklin Resources, exiting entirely with an estimated $1.08M sold.

  • 72 institutional investors held Invacare Corporation (IVC) as of Q3 2022, down from 83 in Q2 2022.
  • Funds reported $14.8M of Invacare Corporation stock for Q3 2022, down 44% quarter-over-quarter.
  • 10 funds opened new Invacare Corporation positions in Q3 2022 and 20 closed out, a net change of -10 holders.
  • The largest Invacare Corporation buyer in Q3 2022 was First Manhattan, an estimated $1.48M added.
  • The largest Invacare Corporation seller in Q3 2022 was Franklin Resources, an estimated $1.08M sold.

Based on aggregated 13F filings for Q3 2022.